Stock Taper
SCREENER COMPARE ANY 2 STOCKS
IDXX
IDEXX LABORATORIES, INC.
NASDAQ
$554.99
▲ UP 1.82% (9.91)

KEY STATISTICS

Market Cap$43.78 B
52w High$769.98
52w Low$518.55
Dividend Yield—
Frequency—
P/E39.03
Volume340.35K
Shares Out.78.88M

COMPANY

LEADERSHIP

Michael Erickson
CHIEF EXECUTIVE
Michael Erickson

COMPENSATION 2026

Salary$1,150,000
Stock Awards$5,399,881
Incentive Plan Pay$2,593,000
All Other Comp.$37,240
Total$14,580,122

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 21, 1991
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
11,000

PRICE TARGET

Target High$710.00
Target Low$620.00
Target Median$665.00
Target Consensus$665.00

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$1.19B
NOV
2
MON

SPLIT RECORD

DATETYPERATIO
2015-06-16Forward2:1
2007-11-27Forward2:1
1995-06-06Forward2:1
1993-10-04Forward2:1

PRICE

$554.99 ▲ UP 1.82% (+$9.91)
OVERLAYS
$546$549$552$5559:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM554.99

About IDEXX Laboratories, Inc.

https://www.idexx.com ↗

IDEXX Laboratories develops and distributes veterinary, livestock, water testing, and biomedical diagnostic products and services worldwide, serving veterinary clinics, research, and water quality markets.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT IDEXX LABORATORIES, INC. IS KNOWN FOR

inVue Dx Cellular Analyzer
inVue Dx Cellular Analyzer

The inVue Dx is an in-clinic cellular analyzer that enhances diagnostic accuracy and workflow efficiency for veterinarians, driving rapid adoption and company growth.

COMPETITORS

COMPETITOR
ELAN COMPARE
NEOG COMPARE
TMO COMPARE
ZTS COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$656.16M $652.44M ▼$666.12M ▲$718.63M ▲
Service$449.08M $438.14M ▼$474.7M ▲$497.96M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$705.04M $675.01M ▼$725.23M ▲$772.97M ▲
EMEA$245.06M $254.37M ▲$257.05M ▲$265.53M ▲
Asia Pacific$90.72M $94.17M ▲$94.38M ▲$101.5M ▲
CANADA$41.38M $41.96M ▲$40.94M ▼$50.79M ▲
Latin America$23.04M $45.05M ▲$23.21M ▼$25.81M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
1,038
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.06% · 2.5M
QQQ
0.19% · 1.7M
IVV.AX
0.07% · 1.1M
SPY
0.06% · 968.1K
SCHG
0.16% · 191.1K
FIW
3.40% · 118.5K
DUHP
0.49% · 115.7K
GSLC
0.28% · 78.6K
NULG
1.29% · 72.1K
XDWE.L
0.18% · 55.0K
QQQI
0.19% · 49.8K
TQQQ
0.07% · 47.7K
VETS
4.15% · 44.2K
U127.L
0.20% · 44.1K
JQUA
0.25% · 40.3K
FHLC
0.59% · 38.1K
HMWD.L
0.11% · 37.3K
QYLD
0.19% · 29.3K
AVUS
0.11% · 29.0K
TCAF
0.19% · 28.9K
XZ
XZME.F
0.15% · 27.3K
SEIQ
1.99% · 26.3K
FLQM
0.90% · 26.1K
QQQE
0.94% · 25.7K
WSRUS.SW
0.20% · 25.5K
ZSP.TO
0.06% · 24.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
76.33%
HOLDERS
1,896
TOP 12 OF 1,896 · RANKED BY POSITION SIZE
Vanguard Group Inc
10.0M sh · $6.36B
Blackrock Inc.
9.6M sh · $4.68B
Blackrock, Inc.
8.5M sh · $5.77B
Elyxium Wealth, LLC
5.4M sh · $5.44M
Fundsmith Equity Fund, L.P.
4.4M sh · $965.28M
State Street Corp
3.7M sh · $1.97B
Blackrock Fund Advisors
3.7M sh · $435.48M
Invesco Ltd.
3.6M sh · $1.9B
Blackrock Institutional Trust Company, N.A.
3.3M sh · $382.6M
Geode Capital Management, LLC
2.7M sh · $1.5B
J. Stern & Co. Llp
2.7M sh · $2.65M
Fundsmith Llp
2.6M sh · $1.67B

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Purchase
2026-04-13
 April Delaney
April Delaney
Sale
2026-01-13
 Byron Donalds
Byron Donalds
Purchase
2025-09-04
 Rob Bresnahan
Rob Bresnahan
Purchase
2025-05-15

INSIDER TRADES

★
OFFICER: EVP, CFO AND TREASURER
Emerson Andrew
Purchase · 265 shares
2026-08-20
★
OFFICER: EVP, CFO AND TREASURER
Emerson Andrew
Sale · 86 shares
2026-08-20
★
OFFICER: EVP, CFO AND TREASURER
Emerson Andrew
Sale · 265 shares
2026-08-20
★
DIRECTOR
HOOLEY JOSEPH L
Purchase · 49 shares
2026-07-30

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 3
NEUTRAL 3
BUY 2
8 GRADES IN THE LAST 12 MONTHS
Barclays OVERWEIGHT UBS NEUTRAL Citigroup NEUTRAL Stifel BUY Piper Sandler NEUTRAL BTIG BUY Morgan Stanley OVERWEIGHT JP Morgan OVERWEIGHT

SECTORS PEERS

PEERPRICE
ARGX$1023.21COMPARE
COR$322.03COMPARE
CAH$234.55COMPARE
BDX$189.52COMPARE
EW$90.21COMPARE
VEEV$276.69COMPARE
A$153.85COMPARE
IQV$261.75COMPARE